Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001171843-15-000870)

Filing Details

Accession Number:: 0001171843-15-000870
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2015-02-17 15:33:05
Reporting Period:: 2014-12-10

Filing Date:: 2015-02-17
Accepted Time:: 2015-02-17 15:33:05
Original Submission Date:: 2014-12-12
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1361248	Tetralogic Pharmaceuticals Corp	TLOG	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1589565	Glenn Colin Begley	C/O Tetralogic Pharmaceuticals Corp 343 Phoenixville Pike Malvern PA 19355	Chief Scientific Officer & Svp	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock - Colin Glenn Begley	Acquisiton	2014-12-10	6,000	$6.16	198,234	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock - Ryan Alexander Begley (Son)	1,100	Indirect	By family member

Footnotes

The total amount of securities purchased on 12/10/2014 was inadvertently under-reported by 100 shares and therefore has been revised from 5,900 shares to 6,000 shares.
Reported when acquired and inadvertently omitted from Section 5 on Form 4 filed on 12/12/2014.